<?xml version="1.0" encoding="UTF-8"?>
<p id="Par11">Treatment included corticosteroids and intravenous or oral ribavirin. Although published data are not yet available in humans, animal models suggest that monoclonal antibody to SARS coronavirus (SARS-CoV) is effective in decreasing viral replication and improving outcomes [
 <xref ref-type="bibr" rid="CR26">26</xref>]. The overall case fatality rate during the SARS epidemic was nearly 10% [
 <xref ref-type="bibr" rid="CR19">19</xref>]. A novel coronavirus was rapidly isolated and identified as the cause of SARS and sequenced, allowing for RT-PCR and serologic testing to be developed [
 <xref ref-type="bibr" rid="CR29">29</xref>, 
 <xref ref-type="bibr" rid="CR30">30</xref>].
</p>
